Guardian Bio is a startup based in the United States, 2 tracked investors.
Based in the United States, Guardian Bio is a startup founded in 2020. Brouky records 2 investors associated with the company.
Guardian Bio develops a proprietary process to generate true cDC1 dendritic cells from patients’ stem cells to restore antigen presentation and enhance anti-cancer immunity in late stage solid tumor patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.